CN113671048A - Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue - Google Patents

Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue Download PDF

Info

Publication number
CN113671048A
CN113671048A CN202010402175.0A CN202010402175A CN113671048A CN 113671048 A CN113671048 A CN 113671048A CN 202010402175 A CN202010402175 A CN 202010402175A CN 113671048 A CN113671048 A CN 113671048A
Authority
CN
China
Prior art keywords
toluenesulfonate
solution
ethyl
mobile phase
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010402175.0A
Other languages
Chinese (zh)
Inventor
刘蓓蓓
陈云建
陈斌
杨建玲
涂继辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KPC Pharmaceuticals Inc
Original Assignee
KPC Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KPC Pharmaceuticals Inc filed Critical KPC Pharmaceuticals Inc
Priority to CN202010402175.0A priority Critical patent/CN113671048A/en
Publication of CN113671048A publication Critical patent/CN113671048A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724Nebulising, aerosol formation or ionisation
    • G01N30/7266Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8679Target compound analysis, i.e. whereby a limited number of peaks is analysed

Abstract

The invention discloses a method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residues, which comprises the following steps of: (1) weighing a high piperazine product, adding a solvent for dissolving, fixing the volume, and uniformly mixing to obtain a test solution; (2) preparing a reference substance solution and a sensitivity solution; (3) the determination is carried out by adopting a liquid chromatography-mass spectrometry combined method: the liquid chromatography determination conditions were: gradient elution is carried out on a mobile phase A which is a pure water solution of 0.1% formic acid and a mobile phase B which is a methanol solution of 0.1% formic acid, the column temperature is 40 ℃, the flow rate is 0.6ml per minute, the sample injection temperature is 5 ℃, and the sample injection volume is 5 mu l; the mass spectrum conditions are as follows: an ion source API-ES adopts a mass spectrum scanning mode of multi-reaction monitoring; the inlet voltage is 8V, the outlet voltage is 10V, the air curtain pressure is 25Psi, the collision gas CAD is 10Psi, the spray voltage is 5500V, and the ion source temperature is 430 ℃; the atomization gas pressure was 55Psi and the assist gas pressure was 55 Psi. The method is suitable for detecting the two impurities in the homopiperazine.

Description

Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue
Technical Field
The invention belongs to the field of medicine quality control, particularly relates to a detection method of residues in homopiperazine, and more particularly relates to a detection method of residues in homopiperazine, namely methyl p-toluenesulfonate and ethyl p-toluenesulfonate.
Background
The homopiperazine is synthesized by using ethylenediamine as a starting material and performing three-step reactions of sulfonylation, cyclization and desulfonylation, wherein methyl p-toluenesulfonate (MTS), ethyl p-toluenesulfonate (ETS) and other unknown impurities may remain, and the homopiperazine is used as a starting material for medicine synthesis, so that the residues of methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) need to be detected and controlled in quality control.
The application number 2015100770097 discloses a method for preparing homopiperazine, which comprises the steps of using ethylenediamine as a raw material, carrying out acylation reaction with p-toluenesulfonyl chloride in an N-butanol solvent to obtain N, N '-di-p-toluenesulfonyl ethylenediamine, directly carrying out cyclization reaction with bromochloropropane under the action of sodium hydroxide without separating a product from a reaction solution to obtain N, N' -di-p-toluenesulfonyl homopiperazine, then carrying out desulfonylation under the action of hydrobromic acid and phenol to obtain homopiperazine hydrobromide, and finally carrying out sodium hydroxide dissociation and toluene carrying water to obtain high-purity homopiperazine. The technical scheme does not disclose a method for detecting residues in homopiperazine.
The present invention has been made in view of this situation.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a method for detecting residues in homopiperazine, in particular a method for detecting residues in homopiperazine, namely methyl p-toluenesulfonate and ethyl p-toluenesulfonate.
In order to solve the technical problems, the invention adopts the technical scheme that:
the invention aims to provide a method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue, which comprises the following steps of:
(1) weighing a high piperazine product, adding a solvent for dissolving, fixing the volume, and uniformly mixing to obtain a test solution;
(2) respectively weighing reference substances of methyl p-toluenesulfonate and ethyl p-toluenesulfonate, respectively placing in a measuring flask, adding a solvent for dissolving, fixing the volume, uniformly mixing, and diluting to obtain reference substance stock solution; diluting the reference substance stock solution to a set concentration to serve as a reference substance solution, and diluting the reference substance solution to serve as a sensitivity solution;
(3) the determination is carried out by adopting a liquid chromatography-mass spectrometry combined method:
the liquid chromatography determination conditions were: gradient elution is carried out on a mobile phase A which is a pure water solution of 0.1% formic acid and a mobile phase B which is a methanol solution of 0.1% formic acid, the column temperature is 40 ℃, the flow rate is 0.6ml per minute, the sample injection temperature is 5 ℃, and the sample injection volume is 5 mu l;
the mass spectrum conditions are as follows: an ion source API-ES adopts a mass spectrum scanning mode of multi-reaction monitoring; the inlet voltage is 8V, the outlet voltage is 10V, the air curtain pressure is 25Psi, the collision gas CAD is 10Psi, the spray voltage is 5500V, and the ion source temperature is 430 ℃; the atomization gas pressure was 55Psi and the assist gas pressure was 55 Psi.
In the further scheme, in the step (1) and the step (2), the solvent is a mixed solution of acetonitrile and water with the volume percentage of 0.5% formic acid.
In a further embodiment, the volume ratio of 0.5% formic acid in acetonitrile to 0.5% formic acid in water in the mixed solution is 30-50: 50-70.
In a further embodiment, the volume ratio of 0.5% formic acid in acetonitrile to 0.5% formic acid in water in the mixed solution is 30: 70.
In a further scheme, in the step (3), the time and the mobile phase ratio of gradient elution are as follows: 0.01-6.00min, the volume percentage of the mobile phase A is reduced from 60% to 5%, the volume percentage of the mobile phase B is increased from 40% to 95% and 6.00-6.10min, the volume percentage of the mobile phase A is increased from 5% to 60%, the volume percentage of the mobile phase B is reduced from 95% to 40% and 6.10-10.00min, the volume percentage of the mobile phase A is maintained at 60%, and the volume percentage of the mobile phase B is maintained at 40%.
In a further embodiment, in the liquid chromatography determination conditions of step (3), the chromatographic column used is an Agilent Zorbax SB-C8 column.
In a further scheme, in the step (3), acetonitrile-pure water is adopted as the needle washing liquid, wherein the volume ratio of the acetonitrile to the pure water is 30: 70.
In a further embodiment, in the step (3), the running time under the liquid chromatography measurement condition is 10 min.
In a further scheme, the signal-to-noise ratio S/N of the methyl p-toluenesulfonate and the ethyl p-toluenesulfonate in the sensitivity solution is not less than 10.
In a further scheme, the peak area is calculated according to an external standard method, and the p-toluenesulfonic acid methyl ester and the p-toluenesulfonic acid ethyl ester are not more than 8 ppm.
The limit requirements for methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) in high piperazine products are each not more than 8 ppm. The structural formula of methyl p-toluenesulfonate (MTS) is shown as the following formula I, and the structural formula of ethyl p-toluenesulfonate (ETS) is shown as the following formula II.
Figure BDA0002489903520000021
As a specific embodiment, the method for detecting the residues of methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) in homopiperazine comprises the following steps:
(1) precisely weighing 50mg of the product, placing the product in a 10ml measuring flask, adding a solvent to dissolve and dilute the product to a scale, and shaking the product uniformly to obtain a test solution. Precisely weighing about 50mg of MTS and about 50mg of ETS respectively, placing the MTS and the ETS into a 50ml measuring flask, dissolving the MTS and the ETS by using a solvent and diluting the MTS and the ETS to scales, shaking up, precisely weighing 80 mu l of the MTS and the ETS, placing the MTS and the ETS into a 20ml measuring flask, diluting the MTS and the ETS to scales by using the solvent and shaking up to obtain a reference substance stock solution; another 0.1ml sample was removed precisely and placed in a 10ml measuring flask, diluted to the mark with solvent and shaken up to give a control solution. 2.0ml of the control solution was precisely measured, placed in a 10ml measuring flask, diluted to the mark with a solvent and shaken up to give a sensitive solution.
(2) The mobile phase A was a 0.1% formic acid solution in pure water (v/v) and the mobile phase B was a 0.1% formic acid solution in methanol (v/v) as determined by liquid chromatography-mass spectrometry (LC-MS), and the conditions of gradient elution and mass spectrometry are shown in Table 1. The column temperature was 40 ℃, the flow rate was 0.6ml per minute, the injection temperature was 5 ℃ and the injection volume was 5. mu.l. The signal-to-noise ratio (S/N) of MTS and ETS in the sensitive solution is not less than 10. The MTS and the ETS both have to exceed 8ppm calculated by peak area according to an external standard method.
TABLE 1
Figure BDA0002489903520000022
Figure BDA0002489903520000031
The solvent in step (1) was 0.5% formic acid in acetonitrile-water (30: 70, v/v).
The chromatographic column used in step (2) was an Agilent Zorbax SB-C8 column (4.6X 75mm, 3.5 μm).
After adopting the technical scheme, compared with the prior art, the invention has the following beneficial effects:
1. in the detection method, the diluent adopts a mixed solution of 0.5% of formic acid acetonitrile and 0.5% of formic acid water (the volume ratio is 30-50:50-70) as the diluent, so that the hydrolysis of methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) is inhibited, the methyl p-toluenesulfonate (MTS) and the ethyl p-toluenesulfonate (ETS) are directly detected, and the method is simple.
2. The detection method of the residues in the high piperazine, namely methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS), provided by the invention, proves that the method can be used for the detection method of the residues in the high piperazine, namely methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS), through the methodological research on the specificity, the system applicability, the linear range, the quantitative limit/detection limit, the recovery rate, the accuracy, the precision, the solution stability and the method durability of the method, the separation detection effect is good, and the guarantee can be provided for the quality control of the high piperazine.
The following describes embodiments of the present invention in further detail with reference to the accompanying drawings.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention, are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the invention without limiting the invention to the right. It is obvious that the drawings in the following description are only some embodiments, and that for a person skilled in the art, other drawings can be derived from them without inventive effort. In the drawings:
FIG. 1 is a chromatogram obtained by detection using mobile phase 1 in example 1; a is a chromatogram of a sample obtained by adopting mobile phase 1 detection; b is a chromatogram of a positive control, and C is a chromatogram of a negative control;
FIG. 2 is a chromatogram obtained by detection using mobile phase 2 in example 1; a is a chromatogram of a sample obtained by adopting mobile phase 2 detection; b is a chromatogram of a positive control, and C is a chromatogram of a negative control;
FIG. 3 is a chromatogram obtained by detection using mobile phase 3 in example 1; a is a chromatogram of a sample obtained by adopting mobile phase 3 detection; b is a chromatogram of a positive control, and C is a chromatogram of a negative control;
FIG. 4 shows diluent 1 (50% H) used in example 22O-50% ACN) for detecting chromatograms of 1000ng/mL MTS (A) and ETS (B) control solutions;
FIG. 5 shows diluent 1 (50% H) used in example 22O-50% ACN) to detect the chromatogram of the test solution added with 1000ng/mL MTS and ETS; wherein MTS is not detected (A), ETS is detected (B);
FIG. 6 shows diluent 2 (50% H) used in example 22O-50% ACN-0.1% FA) detecting the chromatogram of the control solution of MTS and ETS of 1000 ng/mL; wherein MTS is not detected (A), ETS is detected (B);
FIG. 7 shows diluent 2 (50% H) used in example 22O-50% ACN-0.1% FA) detection spiked 1Chromatograms of test solutions of 000ng/mL MTS and ETS; wherein MTS is not detected (A), ETS is detected (B);
FIG. 8 shows diluent 3 (50% H) used in example 22O-50% ACN-0.5% FA) detecting the chromatogram of the control solution of MTS and ETS of 1000 ng/mL; wherein A is an MTS contrast solution chromatogram, and B is an ETS contrast solution chromatogram;
FIG. 9 shows diluent 3 (50% H) used in example 22O-50% ACN-0.5% FA) to detect the chromatogram of the test solution of MTS and ETS added with standard 1000 ng/mL; wherein MTS (A) and ETS (B) are measured;
FIG. 10 is a chromatogram of a control obtained by the assay of example 3; wherein, STD is 40 ng/mL;
FIG. 11 is a chromatogram of a spiked sample detected in example 3; wherein, 100% Spiked is 5 mg/mL;
FIG. 12 is a chromatogram of blank, control solution and spiked sample solution in the specificity test in test example 2;
FIG. 13 is a graph showing the linearity (20% to 200%) of methyl p-toluenesulfonate in test example 5;
FIG. 14 is a graph showing the linearity (20% to 200%) of ethyl p-toluenesulfonate in test example 5.
It should be noted that the drawings and the description are not intended to limit the scope of the inventive concept in any way, but to illustrate it by a person skilled in the art with reference to specific embodiments.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and the following embodiments are used for illustrating the present invention and are not intended to limit the scope of the present invention.
Example 1
In this example, methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) were hydrolyzed to p-toluenesulfonic acid under alkaline conditions, and MTS and ETS were indirectly quantified by detecting p-toluenesulfonic acid.
Precisely weighing 50mg of the product, placing the product in a 10ml measuring flask, adding a solvent to dissolve and dilute the product to a scale, and shaking the product uniformly to obtain a test solution. Precisely weighing about 50mg of MTS and about 50mg of ETS respectively, placing the MTS and the ETS into a 50ml measuring flask, dissolving the MTS and the ETS by using a solvent and diluting the MTS and the ETS to scales, shaking up, precisely weighing 80 mu l of the MTS and the ETS, placing the MTS and the ETS into a 20ml measuring flask, diluting the MTS and the ETS to scales by using the solvent and shaking up to obtain a reference substance stock solution; another 0.1ml sample was removed precisely and placed in a 10ml measuring flask, diluted to the mark with solvent and shaken up to give a control solution.
Several basic mobile phases were tried in this example, and the liquid phase conditions in table 2 below were specifically used for the detection.
TABLE 2
Figure BDA0002489903520000041
As a result:
the chromatogram, positive control (MS positive scan), and negative control (MS negative scan) of the sample obtained by mobile phase 1 assay are shown in A, B, C in FIG. 1, the chromatogram, positive control, and negative control chromatogram obtained by mobile phase 2 assay are shown in A, B, C in FIG. 2, and the chromatogram, positive control, and negative control chromatogram obtained by mobile phase 3 assay are shown in A, B, C in FIG. 3.
And (4) conclusion: in the three mobile phase systems, MTS and ETS are not easy to hydrolyze when the control is tested, and MTS and ETS cannot be detected by measuring p-toluenesulfonic acid.
TABLE 3
Figure BDA0002489903520000042
Figure BDA0002489903520000051
Example 2
MTS hydrolyzed in the spiked solution at a sample concentration of 10mg/mL, and ETS was not hydrolyzed. An attempt was made to adjust the pH of the sample solution by adding formic acid to the diluent in an amount such that M isTS and ETS can keep the prototype, inhibit its hydrolysis, and directly detect it. 3 different diluents (i.e. solvents to formulate the sample) were tried, respectively: diluent 1: 50% H2O-50% ACN, diluent 2: 50% H2O-50% ACN-0.1% FA, diluent 3: 50% H2O-50% ACN-0.5% FA, and were tested using the test conditions as set forth in Table 4 below.
TABLE 4
Figure BDA0002489903520000052
As a result:
the chromatogram obtained by the detection with the diluent 1 is shown in fig. 4-5, MTS in the labeled sample is not detected, and ETS can be detected; the chromatogram obtained by the detection of the diluent 2 is shown in fig. 6-7, the MTS peak value in the labeled sample is very small, and ETS can be detected; the chromatograms obtained by using diluent 3 for detection are shown in FIGS. 8-9, and MTS and ETS in the labeled sample can be detected.
TABLE 5
Diluent (solvent) Whether MTS in the spiked solution is hydrolyzed Whether ETS in the target solution is hydrolyzed
50%H2O-50%ACN Is that Whether or not
50%H2O-50%ACN-0.1%FA Is that Whether or not
50%H2O-50%ACN-0.5%FA Whether or not Whether or not
The results in three different diluents show that at 50% H2Both MTS and ETS were detected in spiked samples in O-50% ACN-0.5% FA. This solvent was therefore selected for subsequent process studies.
The MTS in spiked solution was found to be more stable when the diluent water ratio was high, using 0.5% FA in H2O: 0.5% FA in ACN 7:3 as solvent, while the temperature of the sample plate is controlled at 5 ℃ under which the MTS and ETS in the standard solution are stabilized for at least 12 h.
Example 3
The detection method for MTS and ETS residues in homopiperazine is pre-verified, and the detection conditions and results are shown in Table 6.
TABLE 6
Figure BDA0002489903520000053
Figure BDA0002489903520000061
The chromatograms obtained by detection are shown in FIG. 10(STD 40ng/mL) and FIG. 11 (100% Spiked 5 mg/mL).
The method has the following characterization results:
1. specificity: no interference was observed during the retention time of MTS, ETS.
2. Sensitivity solution: MTS 8ng/mL (1.6ppm), signal-to-noise ratio S/N54; ETS 8ng/mL (1.6ppm) and signal-to-noise ratio S/N20.
3. Linearity: MTS 8ng/mL to 80ng/mL (1.6to 16ppm, r 0.9989)
ETS:8ng/mL to 80ng/mL(1.6to 16ppm,r=0.9983)
4. Precision:
MTS:
RSD% of 6 repeated injectionsRT0.1% (n ═ 6);
RSD% of 6 repeated injectionsAreaIs 5.6% (n ═ 6)
ETS:
RSD% of 6 repeated injectionsRT0.2% (n ═ 6);
RSD% of 6 repeated injectionsAreaIs 4.3% (n ═ 6)
5. Reproducibility of
MTS, standard addition 4 ppm: the recovery rate is 111%, (n is 2)
Adding standard 8 ppm: the recovery rate is 95%, (n is 2)
Adding standard 12 ppm: the recovery rate is 102%, (n is 2)
ETS, standard addition 4 ppm: the recovery rate is 87%, (n is 2)
Adding standard 8 ppm: the recovery rate is 86%, (n is 2)
Adding standard 12 ppm: the recovery rate is 89%, (n is 2)
6. Stability of
MTS is stable in the diluent for at least 12 hours, (initial content/12 h content)% > 110.8%
MTS was stable in the spiked solution for at least 12 hours, (initial content/12 h content)% > 108.0%
The ETS is stable in the diluent for at least 12 hours, (initial content/12 h content)% > 91.1%
The ETS was stable in the spiked solution for at least 12 hours, (initial content/12 h content)% > 103.4%
And (4) conclusion: the method pre-verification result shows that the result meets the acceptance standard and the method verification can be carried out.
Test example 1 System Adaptation/method parameters
(1) Experimental methods
Validation studies using chromatographic systems that meet system adaptability requirements in methods
(2) Acceptance criteria
The system is clean and stable, and has no interference at the peak position of the main peak. The peak area of the interference peak, if any, is no more than 30% of the peak area of the main peak in the sensitivity solution.
The signal-to-noise ratio (S/N) of MTS and ETS in the sensitive solution is not less than 10
The RSD% of the peak area in the initial 6-pin reference solution is not more than 15.0%
The retention time RSD% in the initial 6-pin control solution was not greater than 1.0%
The recovery rate of the inserted control solution is between 70.0 and 130.0 percent.
Figure BDA0002489903520000071
In the formula: h represents the peak height from the peak top to the baseline; h represents background noise in the chromatogram
As a result: all verification parameters in the system adaptability test result of the method of the invention meet the acceptance standard, and detailed data are shown in tables 7 and 8.
TABLE 7 results of system adaptability test
Figure BDA0002489903520000072
Figure BDA0002489903520000081
Remarking: ND is not detected
TABLE 8 results of system adaptability test
Figure BDA0002489903520000082
Test example 2 specificity
(1) Experimental methods
The following representative samples were prepared: blank (solvent), 100% limit control solution for each test article,
a spiked sample solution to the 100% limit;
and (5) feeding and analyzing the special detection solution.
(2) Acceptance criteria
In the blank chromatogram, there was no significant interference at the target peak. The peak area of the interference peak, if any, must not be greater than 30% of the average integrated area of the main peak of the LOQ.
A single test article control solution at the 100% limit shows the target peak.
The control solution at the 100% limit shows the target peak.
And no interference exists near a target peak in the chromatogram of the standard sample with the limit of 100 percent.
(3) Results
In the blank chromatogram, there was no interfering peak at the retention time of the target peak, and the specificity test sample chromatogram is shown in fig. 12.
The target peaks were well localized and the Retention Times (RT) are shown in Table 9.
And no interference exists near a target peak in the chromatogram of the standard sample with the limit of 100 percent.
TABLE 9 Retention time and degree of separation
Figure BDA0002489903520000083
Figure BDA0002489903520000091
Test example 3 detection Limit (LOD)
(1) Experimental methods
Prepare a 10% limit control solution as LOD solution
LOD solution sample injection analysis 3 times
Calculating the signal-to-noise ratio of the LOD
(2) Acceptance criteria
The signal-to-noise ratio (S/N) of LOD solution per needle is more than or equal to 3
(3) The resulting signal to noise ratio (S/N) calculations are shown in Table 10.
TABLE 10 detection Limit (LOD)
Figure BDA0002489903520000092
Test example 4 quantitative Limit (LOQ)
(1) Experimental methods
A 20% limit control solution was prepared as the LOQ solution,
the sample introduction of the LOQ solution is analyzed for 6 times,
the signal-to-noise ratio of the LOQ is calculated,
the% RSD of the target peak-to-peak area in the six needles LOQ was calculated.
(2) Acceptance criteria
The signal-to-noise ratio (S/N) of each LOQ solution is more than or equal to 10;
the% RSD of the peak-to-peak area of the target peak in the continuous 6-pin LOQ is less than or equal to 30%
(3) Results
The results of the signal to noise ratio (S/N) calculations are shown in tables 11 (limits for quantitation of methyl p-toluenesulfonate) and 12 (limits for quantitation of ethyl p-toluenesulfonate).
TABLE 11 limits of quantitation (methyl p-toluenesulfonate)
Figure BDA0002489903520000093
TABLE 12 limits of quantitation (ethyl p-toluenesulfonate)
Figure BDA0002489903520000101
Test example 5 linearity
(1) Experimental methods
A series of linear test solutions (20%, 50%, 100%, 150%, 200%) were prepared from LOQ to 200% concentration, each solution was analyzed by injection,
calculation equation and regression coefficient (r)
(2) Acceptance criteria
The regression coefficient (r) is more than or equal to 0.990,
reporting regression coefficients, slopes, y-intercept and residual sum of squares
(3) Results
The linearity test results meet the acceptance criteria, see table 13 and fig. 13 and 14.
TABLE 13 results of the Linear test
Figure BDA0002489903520000102
Test example 6 accuracy
(1) Experimental methods
Three spiked sample solutions were prepared with each of the three limiting levels of 50%, 100% and 150% standard solution
Three sample solutions were prepared according to the method
Each solution is injected and analyzed once
Calculate the recovery per solution and the average recovery per concentration level
(2) Acceptance criteria
The recovery of the individual spiked solutions was between 75-120%.
(3) Results
The results of the accuracy experiments are shown in tables 14 (methyl p-toluenesulfonate) and 15 (ethyl p-toluenesulfonate).
TABLE 14 accuracy (methyl p-toluenesulfonate)
Figure BDA0002489903520000111
TABLE 15 accuracy (ethyl p-toluenesulfonate)
Figure BDA0002489903520000112
Test example 7 reproducibility
(1) Experimental methods
6 parts of the spiked sample solution were prepared at the 100% limit level. The three solutions prepared in the accuracy test can also be used for calculating the repeatability, and each solution is injected and analyzed once
% RSD to calculate recovery of 6 spiked solutions
(2) Acceptance criteria
The percent RSD of the recovery rate of 6 parts of 100 percent standard-adding solution is less than or equal to 20 percent
(3) Results
The results are shown in Table 16 (methyl p-toluenesulfonate) and 17 (ethyl p-toluenesulfonate).
TABLE 16 repeatability (methyl p-toluenesulfonate)
Figure BDA0002489903520000113
TABLE 17 repeatability (ethyl p-toluenesulfonate)
Figure BDA0002489903520000121
Experimental example 8 intermediate precision
(1) Experimental methods
Additional investigators prepared 6 solutions of the spiked sample at the 100% limit level at different times.
Each solution is injected and analyzed once
Calculating% RSD for recovery of 12 aliquots of the spiked sample solution at the 100% limit level
(2) Acceptance criteria
The percent RSD of the recovery rate of the solution of the standard added sample is less than or equal to 20 percent
(3) Results
Intermediate precision results are shown in tables 18 (methyl p-toluenesulfonate) and 19 (ethyl p-toluenesulfonate).
TABLE 18 intermediate precision (methyl p-toluenesulfonate)
Figure BDA0002489903520000122
TABLE 19 intermediate precision (ethyl p-toluenesulfonate)
Figure BDA0002489903520000123
Test example 9 solution stability
(1) Experimental methods
A 100% limit level of each of the control solution and spiked sample solution is prepared and these solutions are analyzed at 24 hours or other time periods and compared to freshly prepared control solutions. If there is no stability problem, a 24 hour investigation is required.
The stability period is the time interval for which the acceptance criterion is met.
(2) Acceptance criteria
The content of the stabilizing solution is 70-130% of the initial content.
(3) Results the solution stability results are shown in tables 20 and 21.
Table 20100% solution stability of control solution
Figure BDA0002489903520000131
TABLE 21100% level spiked sample solution stability
Figure BDA0002489903520000132
Test example 10 Range
(1) Experimental methods
Data determination according to method linearity and accuracy (50% -150%)
(2) Acceptance criteria
Is free of
(3) Results
The method range is 50% to 150% as demonstrated by the method linearity and accuracy verification results. The results are shown in Table 22.
TABLE 22 method detection Range
Name (R) Range
P-toluenesulfonic acid methyl ester 19.33ng/mL~57.98ng/mL
P-toluenesulfonic acid ethyl ester 19.40ng/mL~58.19ng/mL
Test example 11 durability
(1) Experimental methods
According to the chromatographic conditions in the following table, the influence of small changes of the analytical method on the system is examined.
TABLE 23
Figure BDA0002489903520000133
Figure BDA0002489903520000141
The system adaptability of the method after change needs to be examined during testing.
One aliquot of the spiked sample solution was prepared at the 100% limit, and injected once per condition.
The recovery of the spiked sample solution under durability conditions was calculated.
(2) Acceptance criteria
If the recovery rate of the standard sample solution is between 75 and 120 percent under the durability condition, if the durability method does not meet the requirement, a description can be made.
(3) Results
The results of the system suitability are shown in tables 24-16, and the results of the durability are shown in Table 27.
TABLE 24 results of system adaptability test
Figure BDA0002489903520000142
TABLE 25 results of System Adaptation test
Figure BDA0002489903520000143
TABLE 26 results of System Adaptation testing
Figure BDA0002489903520000144
Figure BDA0002489903520000151
TABLE 27 durability test results
Figure BDA0002489903520000152
Conclusion
All validation parameters met the acceptance criteria, so the method is applicable to residue testing of methyl p-toluenesulfonate (MTS) and ethyl p-toluenesulfonate (ETS) in high piperazine residues.
Although the present invention has been described with reference to a preferred embodiment, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (10)

1. A method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residues is characterized by comprising the following steps of:
(1) weighing a high piperazine product, adding a solvent for dissolving, fixing the volume, and uniformly mixing to obtain a test solution;
(2) respectively weighing reference substances of methyl p-toluenesulfonate and ethyl p-toluenesulfonate, respectively placing in a measuring flask, adding a solvent for dissolving, fixing the volume, uniformly mixing, and diluting to obtain reference substance stock solution; diluting the reference substance stock solution to a set concentration to serve as a reference substance solution, and diluting the reference substance solution to serve as a sensitivity solution;
(3) the determination is carried out by adopting a liquid chromatography-mass spectrometry combined method:
the liquid chromatography determination conditions were: gradient elution is carried out on a mobile phase A which is a pure water solution of 0.1% formic acid and a mobile phase B which is a methanol solution of 0.1% formic acid, the column temperature is 40 ℃, the flow rate is 0.6ml per minute, the sample injection temperature is 5 ℃, and the sample injection volume is 5 mu l;
the mass spectrum conditions are as follows: an ion source API-ES adopts a mass spectrum scanning mode of multi-reaction monitoring; the inlet voltage is 8V, the outlet voltage is 10V, the air curtain pressure is 25Psi, the collision gas CAD is 10Psi, the spray voltage is 5500V, and the ion source temperature is 430 ℃; the atomization gas pressure was 55Psi and the assist gas pressure was 55 Psi.
2. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to claim 1, wherein in step (1) and step (2), the solvent is a mixed solution of acetonitrile and water containing 0.5% by volume of formic acid.
3. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to claim 2, wherein the volume ratio of 0.5% formic acid in acetonitrile to 0.5% formic acid in water in the mixed solution is 30-50: 50-70.
4. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to claim 3, wherein the volume ratio of 0.5% formic acid in acetonitrile to 0.5% formic acid in water in the mixed solution is 30: 70.
5. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to any one of claims 1 to 4, wherein in step (3), the gradient elution time and the mobile phase ratio are as follows: 0.01-6.00min, the volume percentage of the mobile phase A is reduced from 60% to 5%, the volume percentage of the mobile phase B is increased from 40% to 95% and 6.00-6.10min, the volume percentage of the mobile phase A is increased from 5% to 60%, the volume percentage of the mobile phase B is reduced from 95% to 40% and 6.10-10.00min, the volume percentage of the mobile phase A is maintained at 60%, and the volume percentage of the mobile phase B is maintained at 40%.
6. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to any one of claims 1 to 5, wherein the chromatographic column used in the liquid chromatography determination conditions of step (3) is an Agilent Zorbax SB-C8 column.
7. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue according to any one of claims 1 to 6, wherein acetonitrile-pure water is used as the needle washing liquid in step (3), wherein the volume ratio of acetonitrile to pure water is 30: 70.
8. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in the high piperazine residue according to any one of claims 1 to 7, wherein in the step (3), the operation time under the liquid chromatography measurement condition is 10 min.
9. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in the high piperazine residue according to any one of claims 1 to 8, wherein the S/N ratio of methyl p-toluenesulfonate to ethyl p-toluenesulfonate in the sensitive solution is not less than 10.
10. The method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in the high piperazine residue according to any one of claims 1 to 9, wherein the amount of methyl p-toluenesulfonate and ethyl p-toluenesulfonate is not more than 8ppm in terms of peak area by an external standard method.
CN202010402175.0A 2020-05-13 2020-05-13 Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue Pending CN113671048A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010402175.0A CN113671048A (en) 2020-05-13 2020-05-13 Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010402175.0A CN113671048A (en) 2020-05-13 2020-05-13 Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue

Publications (1)

Publication Number Publication Date
CN113671048A true CN113671048A (en) 2021-11-19

Family

ID=78536895

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010402175.0A Pending CN113671048A (en) 2020-05-13 2020-05-13 Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue

Country Status (1)

Country Link
CN (1) CN113671048A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114460203A (en) * 2022-02-15 2022-05-10 浙江海正药业股份有限公司 Method for simultaneously detecting methyl p-toluenesulfinate, ethyl p-toluenesulfinate and isopropyl p-toluenesulfinate in medicine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005021151A (en) * 2002-11-12 2005-01-27 Takeda Chem Ind Ltd Method for screening
CN103435530A (en) * 2013-08-30 2013-12-11 张家港市华昌药业有限公司 Preparation method of D-tryptophan lower alcohol ester hydrochloride with high optical purity
CN104870429A (en) * 2013-05-22 2015-08-26 四川海思科制药有限公司 Benzofuran derivative, preparation method therefor, and medical application thereof
CN107014909A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005021151A (en) * 2002-11-12 2005-01-27 Takeda Chem Ind Ltd Method for screening
CN104870429A (en) * 2013-05-22 2015-08-26 四川海思科制药有限公司 Benzofuran derivative, preparation method therefor, and medical application thereof
CN103435530A (en) * 2013-08-30 2013-12-11 张家港市华昌药业有限公司 Preparation method of D-tryptophan lower alcohol ester hydrochloride with high optical purity
CN107014909A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
GRAHAM E. TAYLOR 等: "Low level determination of p-toluenesulfonate and benzenesulfonate esters in drug substance by high performance liquid chromatography/mass spectrometry", 《JOURNAL OF CHROMATOGRAPHY A》, pages 231 - 237 *
孙朴: "HPLC法测定氢溴酸西酞普兰中的基因毒性杂质对甲苯磺酸乙酯", 《药学研究》, vol. 34, no. 11, 31 December 2015 (2015-12-31), pages 637 - 639 *
孙朴: "HPLC法测定氢溴酸西酞普兰中的基因毒性杂质对甲苯磺酸乙酯", 《药学研究》, vol. 34, no. 11, pages 637 - 639 *
张薇 等: "长春西汀中对甲苯磺酸甲酯和对甲苯磺酸乙酯的LC-MS/MS法测定", 《中国医药工业杂志》, vol. 46, no. 12, 31 December 2015 (2015-12-31), pages 1334 - 1336 *
张薇 等: "长春西汀中对甲苯磺酸甲酯和对甲苯磺酸乙酯的LC-MS/MS法测定", 《中国医药工业杂志》, vol. 46, no. 12, pages 1334 - 1336 *
芦飞等: "LC-MS测定醋酸甲羟孕酮中对甲苯磺酸甲酯及对甲苯磺酸乙酯的含量", 《中国现代应用药学》 *
芦飞等: "LC-MS测定醋酸甲羟孕酮中对甲苯磺酸甲酯及对甲苯磺酸乙酯的含量", 《中国现代应用药学》, no. 05, 31 May 2018 (2018-05-31), pages 657 - 659 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114460203A (en) * 2022-02-15 2022-05-10 浙江海正药业股份有限公司 Method for simultaneously detecting methyl p-toluenesulfinate, ethyl p-toluenesulfinate and isopropyl p-toluenesulfinate in medicine
CN114460203B (en) * 2022-02-15 2023-12-22 浙江海正药业股份有限公司 Method for simultaneously detecting methyl p-toluenesulfonate, ethyl p-toluenesulfonate and isopropyl p-toluenesulfonate in medicine

Similar Documents

Publication Publication Date Title
CN110031557B (en) Method for detecting 5-isoquinoline methyl sulfonate and 5-isoquinoline ethyl sulfonate in fasudil hydrochloride
CN113671048A (en) Method for detecting methyl p-toluenesulfonate and ethyl p-toluenesulfonate in high piperazine residue
CN109900830B (en) Method for separating and determining sulfonamide impurities in celecoxib by adopting HPLC (high performance liquid chromatography) and application
CN117030773B (en) Nuclear magnetism quantitative detection method of di-tert-butyl chloromethyl phosphate
CN109425666B (en) LC-MS analysis method of acyl chloride derivative
CN110836930A (en) Method for measuring content of dichlorobutane in levetiracetam by gas chromatography-mass spectrometry
CN114184699B (en) Method for determining potential genotoxic impurities in esomeprazole sodium by liquid chromatography-mass spectrometry
CN109342604A (en) The detection method of diformazan benzene metabolite in urine
CN113109473B (en) Formaldehyde derivatization test method
CN105911155B (en) Method for separating and measuring related substances of lurasidone hydrochloride intermediate by gas chromatography
CN111505163B (en) Method for detecting phenethyl methane sulfonate substances
CN112034056A (en) Detection method for detecting tetrabutylammonium bromide content in levetiracetam
CN115267003B (en) Method for detecting isomer content of S (-) -4-chloro-3-hydroxybutyric acid ethyl ester
CN115144492B (en) Trace detection method for 3-chloropropionyl chloride in beta-chloropropion ketone
CN117054543B (en) Method for detecting genotoxic impurities in antihypertensive drug
CN117074578B (en) LC-MS/MS quantitative detection method of 2- (methylamino) -ethanol
CN114577927B (en) Method for detecting residual impurities in entacapone
CN111624276B (en) Method for simultaneously detecting genotoxic impurities 5-isoquinoline methyl sulfonate and 5-isoquinoline ethyl sulfonate in fasudil hydrochloride
CN115541734A (en) Method for determining protected amino acid enantiomer by normal phase chromatography
CN117929600A (en) Detection method of 3-piperidine formamide
CN115541731A (en) Analysis method for protecting enantiomer of amino acid
CN115980201A (en) Method for determining piperidine residue
CN114624351A (en) Analysis method for (R) - (-) -1-amino-2-propanol residue in benzene sulfonic acid remazolam bulk drug
CN111257440A (en) GC-HS-based method for determining potential genotoxic impurities in sodium valproate
CN115541730A (en) Method for measuring protected amino acid enantiomer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination